The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio or its related term are showing as below:
XMAD:ROVI'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11 Med: 0.3 Max: 0.52
Current: 0.36
During the past 13 years, the highest Dividend Payout Ratio of Laboratorios Farmaceuticos Rovi was 0.52. The lowest was 0.11. And the median was 0.30.
XMAD:ROVI's Dividend Payout Ratio is ranked better than 53.6% of 444
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs XMAD:ROVI: 0.36
During the past 13 years, the highest Trailing Annual Dividend Yield of Laboratorios Farmaceuticos Rovi was 3.28%. The lowest was 0.30%. And the median was 1.10%.
During the past 12 months, Laboratorios Farmaceuticos Rovi's average Dividends Per Share Growth Rate was -15.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -0.70% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 40.40% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 29.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Laboratorios Farmaceuticos Rovi was 128.60% per year. The lowest was -16.80% per year. And the median was 4.40% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Laboratorios Farmaceuticos Rovi Dividend Payout Ratio Related Terms
Laboratorios Farmaceuticos Rovi Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratorios Farmaceuticos Rovi Dividend Payout Ratio Chart
XMAD:ROVI vs ZTS, UTHR, VTRS: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorios Farmaceuticos Rovi Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio falls into.
Laboratorios Farmaceuticos Rovi Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratorios Farmaceuticos Rovi (XMAD:ROVI) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. Over the past decade, Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio has ranged from 0.11 to 0.52. According to the industry distribution chart, Laboratorios Farmaceuticos Rovi ranks #206 out of 444 companies in the Drug Manufacturers industry, placing it in the top 46.4%.
Is Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio too high?
Laboratorios Farmaceuticos Rovi's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 0.52. Based on the distribution chart, Laboratorios Farmaceuticos Rovi ranks #206 out of 444 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Laboratorios Farmaceuticos Rovi has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorios Farmaceuticos Rovi's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Laboratorios Farmaceuticos Rovi ranks #206 out of 444 companies for Dividend Payout Ratio. This puts Laboratorios Farmaceuticos Rovi in the upper half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, Laboratorios Farmaceuticos Rovi's own Dividend Payout Ratio has ranged from 0.11 to 0.52 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorios Farmaceuticos Rovi's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorios Farmaceuticos Rovi stock overvalued right now?
Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi (XMAD:ROVI) is currently considered Modestly Overvalued. The stock's GF Value™ is €50.99, compared to a current price of €57.40 — trading 12.6% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Laboratorios Farmaceuticos Rovi's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Laboratorios Farmaceuticos Rovi (XMAD:ROVI), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi stock appears to be overvalued.
The current stock price of €57.40 is trading 12.6% above its estimated GF Value™ of €50.99.
GuruFocus considers Laboratorios Farmaceuticos Rovi to be Modestly Overvalued.
Key valuation signals for XMAD:ROVI:
Dividend Payout Ratio: 0.00
GF Value™: €50.99 vs. price of €57.40 (12.6% above fair value)
No single metric tells the full story. See the XMAD:ROVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorios Farmaceuticos Rovi Business Description
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
93GF Score
Get the complete analysis for XMAD:ROVI
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:ROVI has been successfully added to your 
